The global market for Immune System Allergy Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Immune System Allergy Treatment players cover Johnson and Johnson Services, Inc., Sanofi, Allergan plc, Pfizer Inc. and LETIPharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Immune System Allergy Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Immune System Allergy Treatment market, with both quantitative and qualitative data, to help readers understand how the Immune System Allergy Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Immune System Allergy Treatment market and forecasts the market size by Type (Allergy Injection and Sublingual Immunotherapy,), by Application (Hospital, Clinic, Pharmacy and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Allergy Injection
Sublingual Immunotherapy
Segmentation by application
Hospital
Clinic
Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Johnson and Johnson Services, Inc.
Sanofi
Allergan plc
Pfizer Inc.
LETIPharma
ALK-Abell? A/S
Allergy Therapeutics
Stallergenes Greer
GlaxoSmithKline plc
Dermapharm Holding
Chapter Introduction
Chapter 1: Scope of Immune System Allergy Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Immune System Allergy Treatment market size and CAGR, Immune System Allergy Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Immune System Allergy Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Immune System Allergy Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Immune System Allergy Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Johnson and Johnson Services, Inc., Sanofi, Allergan plc, Pfizer Inc., LETIPharma, ALK-Abell? A/S, Allergy Therapeutics, Stallergenes Greer and GlaxoSmithKline plc, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immune System Allergy Treatment Market Size 2017-2028
2.1.2 Immune System Allergy Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Immune System Allergy Treatment Segment by Type
2.2.1 Allergy Injection
2.2.2 Sublingual Immunotherapy
2.3 Immune System Allergy Treatment Market Size by Type
2.3.1 Immune System Allergy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Immune System Allergy Treatment Market Size Market Share by Type (2017-2022)
2.4 Immune System Allergy Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Immune System Allergy Treatment Market Size by Application
2.5.1 Immune System Allergy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Immune System Allergy Treatment Market Size Market Share by Application (2017-2022)
3 Immune System Allergy Treatment Market Size by Player
3.1 Immune System Allergy Treatment Market Size Market Share by Players
3.1.1 Global Immune System Allergy Treatment Revenue by Players (2020-2022)
3.1.2 Global Immune System Allergy Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Immune System Allergy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immune System Allergy Treatment by Regions
4.1 Immune System Allergy Treatment Market Size by Regions (2017-2022)
4.2 Americas Immune System Allergy Treatment Market Size Growth (2017-2022)
4.3 APAC Immune System Allergy Treatment Market Size Growth (2017-2022)
4.4 Europe Immune System Allergy Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Immune System Allergy Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Immune System Allergy Treatment Market Size by Country (2017-2022)
5.2 Americas Immune System Allergy Treatment Market Size by Type (2017-2022)
5.3 Americas Immune System Allergy Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune System Allergy Treatment Market Size by Region (2017-2022)
6.2 APAC Immune System Allergy Treatment Market Size by Type (2017-2022)
6.3 APAC Immune System Allergy Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immune System Allergy Treatment by Country (2017-2022)
7.2 Europe Immune System Allergy Treatment Market Size by Type (2017-2022)
7.3 Europe Immune System Allergy Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immune System Allergy Treatment by Region (2017-2022)
8.2 Middle East & Africa Immune System Allergy Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Immune System Allergy Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immune System Allergy Treatment Market Forecast
10.1 Global Immune System Allergy Treatment Forecast by Regions (2023-2028)
10.1.1 Global Immune System Allergy Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Immune System Allergy Treatment Forecast
10.1.3 APAC Immune System Allergy Treatment Forecast
10.1.4 Europe Immune System Allergy Treatment Forecast
10.1.5 Middle East & Africa Immune System Allergy Treatment Forecast
10.2 Americas Immune System Allergy Treatment Forecast by Country (2023-2028)
10.2.1 United States Immune System Allergy Treatment Market Forecast
10.2.2 Canada Immune System Allergy Treatment Market Forecast
10.2.3 Mexico Immune System Allergy Treatment Market Forecast
10.2.4 Brazil Immune System Allergy Treatment Market Forecast
10.3 APAC Immune System Allergy Treatment Forecast by Region (2023-2028)
10.3.1 China Immune System Allergy Treatment Market Forecast
10.3.2 Japan Immune System Allergy Treatment Market Forecast
10.3.3 Korea Immune System Allergy Treatment Market Forecast
10.3.4 Southeast Asia Immune System Allergy Treatment Market Forecast
10.3.5 India Immune System Allergy Treatment Market Forecast
10.3.6 Australia Immune System Allergy Treatment Market Forecast
10.4 Europe Immune System Allergy Treatment Forecast by Country (2023-2028)
10.4.1 Germany Immune System Allergy Treatment Market Forecast
10.4.2 France Immune System Allergy Treatment Market Forecast
10.4.3 UK Immune System Allergy Treatment Market Forecast
10.4.4 Italy Immune System Allergy Treatment Market Forecast
10.4.5 Russia Immune System Allergy Treatment Market Forecast
10.5 Middle East & Africa Immune System Allergy Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Immune System Allergy Treatment Market Forecast
10.5.2 South Africa Immune System Allergy Treatment Market Forecast
10.5.3 Israel Immune System Allergy Treatment Market Forecast
10.5.4 Turkey Immune System Allergy Treatment Market Forecast
10.5.5 GCC Countries Immune System Allergy Treatment Market Forecast
10.6 Global Immune System Allergy Treatment Forecast by Type (2023-2028)
10.7 Global Immune System Allergy Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson and Johnson Services, Inc.
11.1.1 Johnson and Johnson Services, Inc. Company Information
11.1.2 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Offered
11.1.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson and Johnson Services, Inc. Main Business Overview
11.1.5 Johnson and Johnson Services, Inc. Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Immune System Allergy Treatment Product Offered
11.2.3 Sanofi Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Allergan plc
11.3.1 Allergan plc Company Information
11.3.2 Allergan plc Immune System Allergy Treatment Product Offered
11.3.3 Allergan plc Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Allergan plc Main Business Overview
11.3.5 Allergan plc Latest Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Information
11.4.2 Pfizer Inc. Immune System Allergy Treatment Product Offered
11.4.3 Pfizer Inc. Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Inc. Main Business Overview
11.4.5 Pfizer Inc. Latest Developments
11.5 LETIPharma
11.5.1 LETIPharma Company Information
11.5.2 LETIPharma Immune System Allergy Treatment Product Offered
11.5.3 LETIPharma Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 LETIPharma Main Business Overview
11.5.5 LETIPharma Latest Developments
11.6 ALK-Abell
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)